$380 Million is the total value of Endurant Capital Management LP's 63 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 103.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -66,666 | -100.0% | 0.00% | – |
| ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -18,125 | -100.0% | -0.12% | – |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -84,295 | -100.0% | -0.14% | – |
| HGEN | Exit | HUMANIGEN INC | $0 | – | -154,613 | -100.0% | -0.14% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -44,847 | -100.0% | -0.14% | – |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -22,489 | -100.0% | -0.24% | – |
| TMCI | Exit | TREACE MED CONCEPTS INC | $0 | – | -57,175 | -100.0% | -0.26% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -245,764 | -100.0% | -0.28% | – |
| NRIX | Exit | NURIX THERAPEUTICS INC | $0 | – | -43,542 | -100.0% | -0.30% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -165,404 | -100.0% | -0.36% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -66,935 | -100.0% | -0.37% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -24,253 | -100.0% | -0.41% | – |
| PODD | Exit | INSULET CORP | $0 | – | -6,394 | -100.0% | -0.41% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -68,599 | -100.0% | -0.54% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -160,640 | -100.0% | -0.63% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -12,000 | -100.0% | -0.64% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -244,125 | -100.0% | -0.69% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -33,191 | -100.0% | -0.72% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -87,343 | -100.0% | -0.87% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -73,914 | -100.0% | -0.95% | – |
| RCM | Exit | R1 RCM INC | $0 | – | -205,400 | -100.0% | -1.26% | – |
| OCDX | Exit | ORTHO CLINICAL DIAGNOSTICS H | $0 | – | -245,484 | -100.0% | -1.27% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -29,543 | -100.0% | -1.43% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -42,762 | -100.0% | -1.77% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -34,452 | -100.0% | -2.09% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -172,384 | -100.0% | -2.32% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -115,003 | -100.0% | -3.69% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -424,490 | -100.0% | -5.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.